What Information Should Be Required to Support Clinical “Omics” Publications?
- 1 May 2011
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (5) , 688-690
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Disclose all data in publicationsNature, 2010
- Accessible Reproducible ResearchScience, 2010
- Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biologyThe Annals of Applied Statistics, 2009
- RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialThe Lancet Oncology, 2007
- Microarrays: retracing stepsNature Medicine, 2007
- Pharmacogenomic Strategies Provide a Rational Approach to the Treatment of Cisplatin-Resistant Patients With Advanced CancerJournal of Clinical Oncology, 2007
- Genomic signatures to guide the use of chemotherapeuticsNature Medicine, 2006
- RETRACTED: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)JNCI: Journal of the National Cancer Institute, 2005
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005